RELFYDESS Trademark

Trademark Overview


On Tuesday, October 3, 2023, a trademark application was filed for RELFYDESS with the United States Patent and Trademark Office. The USPTO has given the RELFYDESS trademark a serial number of 79386869. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, May 7, 2024. This trademark is owned by Galderma Holding SA. The RELFYDESS trademark is filed in the Cosmetics & Cleaning Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Medicinal preparations based on a dermatological preparation in the nature of medicated dermatological preparations and substances, alone or in kits, including but not limited to, pre-filled syringes, for the treatment of filling wrinkles, folds, scars, and lips, for face and body contour and skin rejuvenation; medicinal preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; pharmaceutical preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; injectable pharmaceutical products, namely, injectable dermal filler; injectable gels for use in the treatment and repair of joint cartilage; injectable dermal filler products, namely, injectable dermal fillers; ph...

Cosmetic preparations based on medicinal liquids and a gel for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; non-medicated skin care preparations; cosmetic preparations for wrinkled skin treatment; non-medicated anti-wrinkle skin care preparations

Medical devices, namely, implants consisting of artificial materials in gel form used for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products
relfydess

General Information


Serial Number79386869
Word MarkRELFYDESS
Filing DateTuesday, October 3, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, May 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesMedicinal preparations based on a dermatological preparation in the nature of medicated dermatological preparations and substances, alone or in kits, including but not limited to, pre-filled syringes, for the treatment of filling wrinkles, folds, scars, and lips, for face and body contour and skin rejuvenation; medicinal preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; pharmaceutical preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; injectable pharmaceutical products, namely, injectable dermal filler; injectable gels for use in the treatment and repair of joint cartilage; injectable dermal filler products, namely, injectable dermal fillers; pharmaceutical preparations for skin care; muscle relaxants
Goods and ServicesCosmetic preparations based on medicinal liquids and a gel for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; non-medicated skin care preparations; cosmetic preparations for wrinkled skin treatment; non-medicated anti-wrinkle skin care preparations
Goods and ServicesMedical devices, namely, implants consisting of artificial materials in gel form used for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products

Classification Information


International Class003 - Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.
US Class Codes001, 004, 006, 050, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code003
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, January 5, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalderma Holding SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Party NameGalderma Holding SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, January 9, 2024APPLICATION FILING RECEIPT MAILED
Wednesday, April 17, 2024NOTICE OF PUBLICATION
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Friday, March 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 4, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 12, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 22, 2024ASSIGNED TO EXAMINER